Cytosorbents Corporation logo

Cytosorbents Corporation

NASDAQ:CTSO

Overview | Financials
Company Name Cytosorbents Corporation
Symbol CTSO
Currency USD
Price 1.42
Market Cap 77,290,032
Dividend Yield 0%
52-week-range 0.7 - 2.15
Industry Medical Devices
Sector Healthcare
CEO Dr. Phillip P. Chan M.D., Ph.D.
Website https://www.cytosorbents.com

An error occurred while fetching data.

About Cytosorbents Corporation

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications,

Related Stocks

Lucid Diagnostics Inc. logo

Lucid Diagnostics Inc.

LUCD

0.832 USD

Tabula Rasa HealthCare, Inc. logo

Tabula Rasa HealthCare, Inc.

TRHC

10.5 USD

Xilio Therapeutics, Inc. logo

Xilio Therapeutics, Inc.

XLO

0.815 USD

Adverum Biotechnologies, Inc. logo

Adverum Biotechnologies, Inc.

ADVM

6.99 USD

Capricor Therapeutics, Inc. logo

Capricor Therapeutics, Inc.

CAPR

5.12 USD

Alzamend Neuro, Inc. logo

Alzamend Neuro, Inc.

ALZN

1.73 USD

HOOKIPA Pharma Inc. logo

HOOKIPA Pharma Inc.

HOOK

4.62 USD

Puma Biotechnology, Inc. logo

Puma Biotechnology, Inc.

PBYI

2.5 USD

Financials

Numbers are in millions USD

Numbers are in millions USD